# FDA Inspection 1158613 - Sutter Medical Center, Sacramento - December 03, 2021

Source: https://www.keypedia.com/records/fda_inspections/sutter-medical-center-sacramento/0f981c8b-4722-4cca-b4a0-66879ff3f1b8
Source feed: FDA_Inspections

> FDA Inspection 1158613 for Sutter Medical Center, Sacramento on December 03, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158613
- Company Name: Sutter Medical Center, Sacramento
- Inspection Date: 2021-12-03
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1158613 - 2021-12-03](https://www.keypedia.com/records/fda_inspections/sutter-medical-center-sacramento/94c20ba9-df69-4def-ad2e-0f02cf3d8d32)
- [FDA Inspection 800772 - 2012-08-27](https://www.keypedia.com/records/fda_inspections/sutter-medical-center-sacramento/0efad76b-6715-480b-8205-5b28c56f5cd3)
- [FDA Inspection 611299 - 2009-09-11](https://www.keypedia.com/records/fda_inspections/sutter-medical-center-sacramento/96c7d461-db44-4036-b256-91de1f24e398)

Company: https://www.keypedia.com/companies/sutter-medical-center-sacramento/af90d7a3-f922-475c-ba1b-d6f0bbcc8d73

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d